alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › treat

treat

3 studies tagged treat, dated 2018-06-01 to 2022-03-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review 2022-03-09
  2. Stem cells: a promising candidate to treat neurological disorders 2018-07-01
  3. Molecular Docking and Dynamic Simulation of AZD3293 and Solanezumab Effects Against BACE1 to Treat Alzheimer's Disease 2018-06-01

Studies

3 studies carry this tag.

Date range

2018 to 2022

Top journals

  • Frontiers in computational neuroscience 1
  • International journal of Alzheimer's disease 1
  • Neural regeneration research 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of Alzheimer's disease 2022-03-09 Treatments

    Despite the limitations, aducanumab is the first disease-modifying therapy approved for the treatment of AD.

  2. Stem cells: a promising candidate to treat neurological disorders

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neural regeneration research 2018-07-01 Brain scans and imaging

    Neurologic impairments are usually irreversible as a result of limited regeneration in the central nervous system.

  3. Molecular Docking and Dynamic Simulation of AZD3293 and Solanezumab Effects Against BACE1 to Treat Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in computational neuroscience 2018-06-01 Treatments

    The design of novel inhibitors to target BACE1 with reduced cytotoxicity effects is a promising approach to treat Alzheimer's disease (AD).

All topic tags with their study counts